![Danny Bar-Zohar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Danny Bar-Zohar
Corporate Officer/Principal chez
MERCK KGAA
Profil
Danny Bar-Zohar is Chief Executive Officer-Healthcare at Merck KGaA since 2025 and Director at SwanBio Therapeutics, Inc. since 2020.
Former roles include Global Head-Clinical Development & Analytics at Novartis Pharma AG from 2013 to 2020 and Partner at Syncona Partners LLP.
Education includes a doctorate from Sackler School of Medicine.
Postes actifs de Danny Bar-Zohar
| Sociétés | Poste | Début |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01/06/2025 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Directeur/Membre du Conseil | 20/11/2020 |
Anciens postes connus de Danny Bar-Zohar
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | - |
Formation de Danny Bar-Zohar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Sackler School of Medicine
 Sackler School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
